Consolidated Statement of Stockholder's Equity - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Capital in excess of par value	Capital in excess of par value Cumulative Effect, Period of Adoption, Adjustment	Retained earnings	Retained earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)	Treasury stock
Balance at beginning of period at Dec. 31, 2021	$ 10,414	$ (245)	$ 888	$ 4,224	$ (300)	$ 15,774	$ 55	$ 388	$ (10,860)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common and treasury stock pursuant to Employee stock plans	46			29					17
Share-based compensation	84			84
Cash dividends	(107)					(107)
Comprehensive income (loss)	495					539		(44)
Balance at end of period at Dec. 31, 2022	10,687		888	4,037		16,261		344	(10,843)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common and treasury stock pursuant to Employee stock plans	50			30					20
Share-based compensation	86			86
Cash dividends	(429)					(429)
Comprehensive income (loss)	121					465		(344)
Balance at end of period at Dec. 31, 2023	10,515		888	4,153		16,297		0	(10,823)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock	(251)								(251)	[1]
Issuance of common and treasury stock pursuant to Employee stock plans	37			7					30
Share-based compensation	45			45
Cash dividends	(430)					(430)
Stock warrants repurchase	(6)			(6)
Comprehensive income (loss)	440					465		(25)
Balance at end of period at Dec. 31, 2024	$ 10,350		$ 888	$ 4,199		$ 16,332		$ (25)	$ (11,044)

[1] Includes excise tax incurred on share repurchases, net of issuances, payable in April 2025.